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4Abstract.  Zinc(II) ions are redox-inert in biology.  Yet, their interaction with sulfur of cysteine in 
cellular proteins can confer ligand-centered redox activity on zinc coordination sites, control protein 
functions, and generate signalling zinc ions as potent effectors of many cellular processes.  The 
specificity and relative high affinity of binding sites for zinc allow regulation in redox biology, free 
radical biology, and the biology of reactive species.  Understanding the role of zinc in these areas of 
biology requires an understanding of how cellular Zn2+ is homeostatically controlled and can serve as 
a regulatory ion in addition to Ca2+, albeit at much lower concentrations.  A rather complex system of 
dozens of transporters and metallothioneins buffer the relatively high (hundreds of micromolar) 
total cellular zinc concentrations in such a way that the available zinc ion concentrations are only 
picomolar but can fluctuate in signalling.  The proteins targeted by Zn2+ transients include enzymes 
controlling phosphorylation and redox signalling pathways.  Networks of regulatory functions of zinc 
integrate gene expression and metabolic and signalling pathways at several hierarchical levels.  They 
affect enzymatic catalysis, protein structure and protein-protein/biomolecular interactions and add 
to the already impressive number of catalytic and structural functions of zinc in an estimated three 
thousand human zinc proteins.  The effects of zinc on redox biology have adduced evidence that zinc 
is an antioxidant.  Without further qualifications, this notion is misleading and prevents a true 
understanding of the roles of zinc in biology.  Its antioxidant-like effects are indirect and expressed 
only in certain conditions because a lack of zinc and too much zinc have pro-oxidant effects.  Teasing 
apart these functions based on quantitative considerations of homeostatic control of cellular zinc is 
critical because opposite consequences are observed depending on the concentrations of zinc: pro- 
or anti-apoptotic, pro- or anti-inflammatory and cytoprotective or cytotoxic.  The article provides a 
biochemical basis for the links between redox and zinc biology and discusses why zinc has pleiotropic 
functions.  Perturbation of zinc metabolism is a consequence of conditions of redox stress.  Zinc 
deficiency, either nutritional or conditioned, and cellular zinc overload cause oxidative stress.  Thus, 
there is causation in the relationship between zinc metabolism and the many diseases associated 
with oxidative stress.
About thirty years ago a review article in this journal discussed a physiological role of the essential 
micronutrient zinc as an antioxidant [1].  Largely from a nutritional perspective, it summarized how 
zinc protects against chemical and physical insults.  Two molecular mechanisms were thought to 
underlie such a function: i) zinc binds to sulfhydryl groups and protects them from modification by 
oxidants and reactive species, and ii) zinc competes with iron and copper in their coordination 
environments and suppresses their redox activity that can generate damaging hydroxyl radicals (OH.) 
through Fenton chemistry.  The authors state that physiological concentrations of zinc do not seem 
to have antioxidant effects while supraphysiological concentrations have antioxidant-like effects in 
organelle- and cell-based systems and pharmacological doses protect the liver and the lung against 
the deleterious effects of pro-oxidants.  They discuss that zinc deficiency causes damage to cellular 
membranes, suggest that oxidative stress† is a component, and conclude that zinc has a general, 
stabilizing and inhibitory effect on many cellular systems and that critical antioxidant functions of 
zinc may still be uncovered.  Another major review ten years later included the now known 
damaging effects of zinc deficiency to DNA and proteins in addition to cellular membranes, and 
added from a medical perspective that zinc can reduce postischemic injury to a variety of tissues [2].  
It concluded that “although the evidence for the antioxidant properties of zinc is compelling, the 
mechanisms are still unclear.”  Key questions regarding the actions of zinc in redox biology remained 
5from these articles, namely: What is the molecular basis for the effects of zinc on redox biology?  Are 
the observed effects general or specific?  And at which concentrations does zinc have antioxidant-
like effects?  In the years following these reviews, it became clear that the entire biological dose-
response relationship must be considered to interpret the effects of zinc on redox biology because 
pro-oxidant effects are observed when the concentrations of zinc are either too low or too high.  
Also, the discovery of molecular mechanisms demonstrated that the above postulated mechanisms 
are not the major ones accounting for the antioxidant-like effects and that zinc has a more general 
role as a regulatory (signalling) ion in controlling some aspects of redox biology.
In this article, the developments in the last two decades are summarized and discussed.  Significant 
findings in zinc biology have strengthened the link between zinc and redox biology and provide a 
quite different interpretation of the earlier literature.  It was discovered how tightly cellular zinc is 
regulated and how this regulation is used for biological control.  The discoveries extended the 
protective effects of zinc to many organ systems, making perturbations of zinc metabolism inevitably 
an important consideration in the pathogenesis of all the diseases linked to redox stress or changes 
of cellular redox state.  The scientific literature on the topic is vast.  Therefore, it is an unattainable 
goal to even summarize just the many reviews.  This review therefore takes a different approach.  It 
provides a framework based on our present knowledge of zinc biology.  Such knowledge will allow 
interpretation of the plethora of reported phenomena.  From understanding the remarkable roles of 
zinc in biology, an understanding will develop why Nature has chosen the redox-inert zinc ion to 
control aspects of redox biology.  Only then the article will briefly allude to the huge implications for 
the complex, system-level functions of zinc in the redox biology of health and disease.  
1. Redox-inert zinc (Zn2+)
In biology, zinc always remains in the Zn(II) valence state and can neither oxidize nor reduce another 
substance.  Therefore, the statement that zinc is redox-inert in biology should be a conversation 
stopper for a journal dedicated to redox biology.  Yet, somewhat paradoxically, it turns out that zinc 
ions (Zn2+) have a central role in the control of redox biology.  
Critically important is an assessment of what is meant by considering redox-inert zinc an antioxidant, 
a connotation adopted by many scientists and the public to describe the characteristics of zinc.  A 
major textbook states that “antioxidant is a term widely used but surprisingly difficult to define 
clearly” and then provides a definition as “any substance that delays, prevents, or removes oxidative 
damage to a molecule” [3].  In the case of zinc, the addition or removal of zinc to/from a biological 
system overcomes a pro-oxidant state caused by a lack of zinc or an excess of zinc.  When employed 
for zinc, the term “antioxidant” is misleading because the redox effects can only be indirect, and the 
effects depend on zinc concentrations.  Therefore, in analogy to the term pro-oxidant, the term pro-
antioxidant has been suggested [4].  These dual functions of zinc in redox metabolism and the need 
to consider its concentrations throughout the entire dose-response curve have been captured in a 
title of a review article that described zinc as an “essential toxin” [5].  The description incorporates 
the fact that zinc is an essential micronutrient and yet can become a toxin when zinc ions are 
released intracellularly from proteins and their concentrations are too high without necessarily 
changing total zinc concentrations.  Furthermore, one needs to distinguish whether any redox 
effects are due to the zinc already present, any zinc added or any perturbation of intracellular 
6equilibria and re-distribution of zinc.  In this article, I will consider the full dose-response curve that 
covers nutrition, pharmacology, and toxicology (Figure 1). 
Figure 1  The redox effects of redox-inert zinc ions.  Zinc present in and added to a biological system 
can have pro-antioxidant or pro-oxidant effects.  Critically important are the control of the very low 
cellular concentrations of “free” zinc ions, [Zn2+]i  and their functions as signalling ions.  The 
concentration is given on a logarithmic scale and corresponds to picomolar concentrations in the 
physiological range in contrast to the total cellular zinc concentration, which is in the range of 
hundreds of micromolar. 
In defining the functions of zinc in redox biology, we need to link the concentrations of both zinc and 
reactive species to either physiology or pathophysiology.  The vast literature on the effects of zinc on 
redox biology must to be read, understood, and interpreted based on what is now known about zinc 
in biology.  With its redox-inert characteristics, zinc is functionally closer to redox-inert magnesium 
and calcium than to the nutritionally essential redox-active transition metal ions manganese, iron, 
and copper, and thus has a special position in the periodic table when related to biology (Figure 2).  
Among the three redox-inert divalent metal ions (Mg2+, Ca2+, Zn2+) it is the one with the strongest 
interaction with donor atoms of ligands.  The consequence of such strong binding (affinity) is that 
zinc is a potent effector at correspondingly lower concentrations.  Accordingly, the three metal ions 
can cover a wide range of concentrations from millimolar to picomolar in biological regulation.   
7Figure 2  Position of zinc in the periodic table.  While zinc is part of the first transition metal 
series/period 4 - though not a transition metal ion itself - its redox-inertness in biology puts it 
functionally closer to magnesium and calcium.  The chemical relationship is also expressed by 
referring to group 2 as group IIa and group 12 as group IIb.  Zinc has higher affinity to biological sites 
than magnesium and calcium.  Accordingly, its available (“free”) concentrations are lower.
2. Zinc biology
The functions of zinc bear on virtually any biological process.  They relate to proteins and are 
catalytic, structural, and regulatory.  The field developed in this order of functions, zinc enzymes, 
zinc proteins, and zinc ions as modulators of enzymes and proteins [6].  The first two are relatively 
well defined in many enzymes and as a way of organizing the structure of proteins.  What is 
understood by “regulatory” has not become evident until relatively recently, however.  Regarding 
enzymatic catalysis, zinc was discovered in carbonic anhydrase about eighty years ago, twenty years 
before it was recognized to be an essential micronutrient for humans [7,8].  The discovery in many 
more enzymes followed so that hundreds of zinc enzymes in all six classes became known [9].  
Discovery was mostly by time-consuming isolation of proteins from their natural sources and 
characterization of their metal content before the advent of molecular cloning and heterologous 
protein expression.  A remarkable development from about the 1980s onward was the discovery of 
zinc in transcription factors, the so-called zinc finger proteins and related motifs.  In these proteins, 
zinc has primarily a structural role [10,11].  Not biochemical preparations but computational 
approaches (bioinformatics) began to make critical contributions.  The reason for the success of 
bioinformatics is that the presence of a putative structural zinc site is more readily recognized than a 
catalytic site in the sequence of proteins because structural sites usually have a characteristic 
signature with four rather closely spaced amino acids, the side chains of which serve as ligands to 
zinc.  Protein and nucleic acid sequence databases were screened for such signatures and many 
more proteins were predicted to be zinc metalloproteins [12].  For both catalytic and structural sites, 
with few exceptions, the ligands are provided by the side chains of Asp/Glu, His, and Cys.  Among 
those amino acids, Cys is the one most frequently employed as a ligand, but not in catalytic sites 
[13].  Signatures of zinc-binding amino acids and “spacers” between them allow searching sequence 
databases for possible zinc-binding sites.  In this way, about a thousand proteins containing zinc 
fingers or related motifs were identified [14].  It demonstrated that zinc sites are a major principle of 
protein structure and biomolecular interactions, namely forming domains of proteins that can 
interact with DNA, RNA, other proteins, and lipids.  Furthermore, many examples emerged where 
zinc is not part of the structure in the protein but binds between subunits to control the assembly of 
proteins in quaternary (same protein) or quinary (different proteins) structure.  Cysteines also 
feature as ligands in such sites.
Once the sequences of entire genomes became available, they could be mined for possible zinc-
binding sites.  Investigators arrived at the remarkable estimate that over three thousand proteins in 
humans have functional zinc-binding sites, meaning that every 10th protein is a zinc protein [15].  
This data mining approach began a new era with a functional annotation of zinc proteins.  The many 
anecdotal observations in zinc biology turned out not to be a matter of lack of specificity but rather 
the consequence of the pleiotropic functions of zinc in such a great number of proteins.  All of these 
functions require tight control.  Three salient developments provide further information of this 
8control, made a great impact on the field, and are critically important for discussing the relationship 
between zinc and redox biology. 
2.1 Proteins regulating zinc. Control of cellular homeostasis
To ascertain that such a large number of zinc proteins receive their zinc at the correct time and 
space in the cell, dozens of proteins, whose sole function is to handle metal ions in the cell and 
subcellularly, are required.  In humans, minimally twenty-four transporters of two protein families 
control the passage of zinc through cellular membranes: 14 ZIP (Zrt- and Irt-like proteins) proteins, 
which are zinc importers and mostly located on the plasma membrane, and 10 ZnT (zinc transporter) 
proteins, which are zinc exporters and mostly located on intracellular membranes [16].  One 
subgroup of ZnTs transports zinc into vesicles for storage or exocytosis of the vesicular content 
together with zinc.  The best characterized systems are synaptic vesicles in some neurons, insulin 
granules of pancreatic β-cells, and granules in epithelial cells of the mammary gland.  In addition, 
about a dozen metallothioneins (MTs) bind zinc in the cell.  This relatively large number of proteins 
and their control by many pathways constitute a rather complex system that interacts with many 
aspects of cellular biology.   
2.2 Affinities of proteins for zinc and cellular zinc buffering 
Quantitative aspects of cellular zinc biology are perhaps least widely acknowledged.  They are critical 
for interpreting the scientific literature on zinc’s cellular functions.  The total cellular zinc 
concentration is rather high, in the hundreds of micromolar, and even higher (millimolar) in some 
subcellular vesicles.  Thus, as far as cellular biochemistry is concerned, zinc is not a trace element.  
The idea of a “trace” comes from the fact that only rather small amounts (2-3 mg) of zinc are needed 
daily in the diet to maintain a total amount of 2-3 g in a 70 kg human.  The bulk of zinc is bound to 
proteins.  The binding capacity and affinity determine how much protein-bound zinc is in equilibrium 
with zinc that is not bound to proteins.  The formalism to describe this binding is rather simple.  In 
analogy to hydrogen ion (proton) buffering (equation 1), there is the concept of metal ion buffering, 
in this case zinc ion buffering (equation 2).
(1) pH = pKa + log[base]/[acid] = - log[H+] (Henderson-Hasselbalch equation)
(2) pZn = pKd + log[ligand]/[Zn-ligand complex] = -log[Zn2+]
(3) E= Eo + 0.059 V/z log[oxidant]/[reductant] (Nernst equation)
The affinities (Kd) of cytosolic zinc proteins for zinc are rather high.  Compared to other nutritionally 
essential metal ions, zinc is a very competitive ion - exceeded only by copper.  The consequence of 
zinc binding to proteins with relatively high affinity is a potency of its biological actions.  The high 
affinity and the relatively large number of binding sites buffer zinc in such a way that the “free” (not 
protein-bound) zinc ion concentration is only in the picomolar range.  It was estimated that in order 
of the magnesium enzyme phosphoglucomutase not to be zinc inhibited, the “free” zinc ion 
concentration in muscle must be <32 pM [17].  In erythrocytes, a concentrations of 24 pM was 
measured [18].  With the advent of fluorescent chelating agents for zinc, a few hundred picomolar 
were determined in several cell lines [19,20].  Thus, zinc ions are buffered at a pZn of about 10.  
Buffering has two components.  First, in analogy to the definition of pH and the Henderson-
Hasselbalch equation (equation 1), it is the pZn value, the “free” zinc ion concentration (equation 2).  
9Second, it is the buffering capacity, which describes how resistant the pZn value is to change.  It is 
determined by the concentrations of zinc-binding ligands and it is in the micromolar range [19].  
Biological buffering also has a kinetic component, referred to as muffling, which describes the 
increase or decrease of zinc ion concentrations effected by the many transporters controlling cellular 
homeostasis [21]. 
Zinc buffering keeps “free” zinc ions in a range of concentrations that make zinc-specific functions in 
zinc metalloproteins possible as it allows separating the functions of zinc from those of other metal 
ions, which are buffered in different ranges.  Knowledge of this zinc buffering is necessary to 
understand the interactions of zinc with proteins ex vivo and in vivo, and to determine the 
appropriate amounts of zinc for experiments in cell and tissue culture.  At least three regions 
describe the actions of zinc: concentrations that provide apoenzymes with zinc, regulate proteins, 
and affect proteins that are normally not targeted (Figure 3).  
Figure 3  The buffering of cellular zinc.  Three regions can be identified (from right to left): a range 
where not enough zinc ions are available either to provide proteins with zinc or to support 
regulatory functions of zinc, an optimal range where such functions are supported, and a range 
where the zinc ion concentrations are too high and interfere with proteins that normally do not 
depend on zinc.
In addition to the pH value, the redox potential affects the pZn value (equation 3).  The ligand 
coordination environments of zinc provide a functional context as they determine how pH and redox 
effects are expressed (Figure 4).  The pH value affects the protonation of ligands of zinc, increasing 
or decreasing “free” zinc ion concentrations at more acidic or more alkaline pH, respectively.  The 
redox potential as described by the Nernst equation (equation 3) affects thiols that bind zinc.  Thus 
any redox changes affecting thiols increases or decreases the “free” zinc ion concentrations.  In the 
cellular context, His coordination environments are mainly pH-sensitive, Cys coordination 
environments are mainly redox-sensitive, and His/Cys environments are both pH and redox-
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sensitive, while Asp/Glu coordination environments are independent of either pH or redox 
conditions.  
Figure 4  Functions of the ligand donor atoms in the biological coordination environments of zinc and 
consequences for zinc buffering (pZn).  Coordination environments with His are pH-sensitive around 
physiological pH.  Coordination environments with Cys are primarily redox-sensitive.  Coordination 
environments with only Asp/Glu do not show these dependences in the cellular context.  Typical pKa 
values are 4.4 for Asp/Glu, 6.5 for His, and 8.5 for Cys.
2.3 Zinc regulating proteins.  Zinc signalling
In recent years, induced fluctuations of ”free” zinc ion concentrations have been shown to be used 
in biological regulation.  In analogy to calcium signalling, they are referred to as zinc signalling.  The 
chemical nature of “free” zinc ions is not known [22].  Given the strong interaction with ligands, zinc 
ions most certainly have a ligand environment other than water molecules.  In addition to controlling 
steady-state zinc concentrations, induced fluctuations of zinc ions need to be controlled.  A 
regulatory role of zinc ions was originally established for the zinc-sensing transcription factor MTF-1 
(metal regulatory element (MRE)-binding transcription factor-1), which interacts with its six zinc 
fingers with DNA and controls the transcription of genes when zinc ion concentrations are elevated.  
The transcriptional response was originally seen mainly as a way of restoring steady-state zinc 
concentrations by inducing MT (zinc-binding) and ZnT1 (zinc export).  However, MTF-1 induces many 
other genes involved in the response to stress such as hypoxia and oxidative stress [23].  In the last 
decade, it became clear that zinc has additional regulatory functions beyond gene expression 
[24,25].  The full impact of zinc ions in regulation is still emerging.  There at least three pathways for 
generating zinc ion signals [26,27].  Zinc ions are exocytosed for autocrine, paracrine and possibly 
endocrine functions.  Zinc ions increase intracellularly when reactive species target zinc thiolate 
coordination environments, which serve as transducers of the redox signal, or when zinc transporter 
channels are opened by phosphorylation.  Zinc ion fluxes intersect with many signalling pathways, 
including phosphorylation, calcium, and redox signalling, with huge implications for signal 
transduction and cell biology:       
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Stimulus → [Zn2+]i → effect on targets in phosphorylation, calcium, and redox signalling
Like calcium transients, zinc transients have amplitudes of about one order of magnitude in 
concentration above baseline values and occur in a zinc-buffered environment.  Also like calcium, a 
more than 4-fold increase is cytotoxic and causes apoptosis.
Some enzymes have been identified as targets of the signalling zinc ions and structurally 
characterized.  The modulation of their activity indicates genuine biological regulation by zinc ion 
fluxes.  Zinc inhibition of enzymes was known for a long time to occur over a range of picomolar 
(pM), nanomolar (nM), and micromolar (µM) concentrations.  The question is which range is 
physiologically significant.  Over sixty years ago, it was reported that picomolar concentrations of 
zinc inhibit phosphoglucomutase, a magnesium enzyme.  The inhibition constant (IC50) is about 2 pM 
[28].  On the other end of the concentration range, the scientific literature is replete with reports of 
zinc inhibiting proteins with micromolar and even millimolar inhibition constants, which some 
investigators consider high affinity sites and discuss as being physiologically meaningful, even in high 
impact journals.  Such interpretations will need to be re-examined as we now know the range of 
“free” zinc ion concentrations.  With quantitative information about the concentrations at which 
zinc ion transients occur and the affinities of proteins targeted, it will be possible to distinguish 
physiological redox and zinc signalling from pathological oxidative stress and associated cytotoxic 
increases in cellular “free” zinc ion concentrations.  
The number of regulatory sites for zinc in proteins is not known.  Many transient zinc binding sites 
have been observed.  They must be evaluated on the basis of their physiological significance and 
added to the already impressive number of about three thousand zinc proteins.  For example, it was 
known that zinc inhibits regulatory enzymes such as caspases and protein tyrosine phosphatases 
[29,30].  However, the inhibition occurs at much lower concentrations than originally reported [31].  
Very specific mechanisms for zinc inhibition were discovered.  For protein tyrosine phosphatase 1B 
(PTP1B), which counteracts the kinase activity of the insulin receptor, the inhibition occurs in the 
closed conformation of the enzyme.  The binding site is thought to include the cysteinyl phosphate 
intermediate and the catalytic aspartate in the active site [32-34].  Zinc inhibition (IC50 = 3-17 nM) 
provides a modulation of activity that differs from the known redox modulation of PTP1B activity, 
which occurs in the open conformation of the enzyme and involves the non-phosphorylated catalytic 
cysteine.  Zinc locks the enzyme in the closed conformation and makes the catalytic cysteine 
inaccessible for oxidation.  Therefore, zinc inhibition of PTP1B is one example where zinc may 
protect an enzyme from oxidative inactivation, albeit not by directly binding to the sulfur of the 
catalytic cysteine.  In the case of receptor protein tyrosine phosphatase β (RPTPβ), zinc inhibition is 
so strong (Ki =21 pM) that the enzyme is thought to be inhibited tonically and needs to be activated 
by zinc removal [35].  Other PTPs are zinc-inhibited as well, suggesting a general effect of zinc on 
phosphorylation signalling [36].  PTEN (phosphatase and tensin homolog), for example, has an IC50 of 
0.6 nM for zinc [37].  In as much as phosphatases are the major regulators in phosphorylation 
signalling and are modulated by zinc inhibition, other hydrolytic zinc enzymes also have a role in 
regulating signalling, e.g. phosphodiesterases that control the degradation of second messengers 
such as cAMP and cGMP.  Lack of zinc in a protein and modulation of function by zinc signalling or 
redox signalling constitute different mechanisms in the repertoire of zinc regulation.  
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Signatures of binding sites of inhibitory zinc ions are not readily identifiable by bioinformatics 
because the ligand donors stem from amino acids located far apart in the amino acid sequence of 
the protein and are brought into proximity only in the folded protein.  Principles of zinc inhibition 
are that zinc competes for magnesium sites in proteins and that many non-metalloenzymes have a 
combination of catalytic residues, e.g. Cys, His, Glu,Asp, in the active site, the diads or triads of which 
provide metal-binding sites.  Accordingly, the concept developed that zinc ions not only bind to 
apoenzymes to form active zinc holoenzymes but also inhibit enzymes that are not zinc enzymes, 
which then need to be activated by zinc removal [38].  The activation mechanism was suggested to 
employ thionein, the apoprotein of MT [31].  Proteins do not necessarily have just one type of zinc 
site.  Either two or all three, i.e. catalytic, structural, and regulatory, types of sites can be present.  
Zinc regulation does not affect only enzymatic functions.  
For membrane proteins, the significance of zinc binding and regulations is less clear, because in 
some cases zinc may bind to sites exposed to the extracellular milieu where zinc buffering is 
different and has not been characterized.  In an extensive list of zinc modulation of ionotropic 
receptors, most of the activating or inhibiting effects of zinc are in the micromolar range, except for 
three examples where inhibition has been observed at much lower zinc concentrations: glycinergic 
(GlyRα1; 80 nM), protonergic (ASIC1a; 7 nM) and glutamatergic (NR1/NR2A; 5 nM) receptors [39].  
Here, too, the observations made on isolated systems must be sorted according to their significance 
for physiology.
The binding of zinc at the interfaces of proteins in protein-protein interactions also depends on zinc 
concentrations [40].  Whether zinc ion fluctuations are employed to control the assembly of protein 
complexes is indicated but less well understood.  A classic example is insulin, where zinc and calcium 
ions are needed for the assembly of the insulin hexamer and its crystallization in the dense granules 
of pancreatic β-cells.  
Zinc buffering and hence the pZn value can change in the cytosol as shown for biological processes 
such as transitions from non-proliferating to proliferating or differentiating cells [19].  The extent to 
which such changes lead to a re-distribution of zinc in the cytosol and between cytosol and cellular 
compartments, changes in the expression of zinc proteins, and differences in loading proteins with 
zinc at their binding sites is also not known.  
In summary, zinc, because of its chemical characteristics, has been chosen for the widest possible 
functions in catalysis, protein structure, and regulation.  Its redox-inertness allows it to be used as a 
signalling ion akin to calcium.  It complements calcium biology, but because of its preference for 
different coordination environments, has different targets and a different action spectrum at lower 
concentrations.  In contrast to the catalytic and structural functions, the significance of regulatory 
functions of zinc in proteins is not as widely acknowledged.  Regulatory functions of zinc will make a 
significant contribution to understanding cellular biology.  
3. The redox activity of zinc-sulfur (thiolate) coordination environments
In contrast to magnesium and calcium, zinc can interact with the sulfur (thiolate) donor ligand of 
cysteine, which is perhaps the most important factor linking zinc and redox/free radical biology [41].  
Zinc thiolate coordination environments can be redox-active [42].  Thus, in contrast to the prevailing 
dogma that zinc protects thiolates as an “antioxidant”, sulfur can be oxidized/modified in some zinc 
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thiolate coordination environments.  In other words, although the central zinc ion is redox-inert, a 
ligand-centered redox chemistry can occur and confer redox activity on the complex [43].  It has 
important consequences for zinc biology as well as redox biology.  Zinc binding can be regulated by 
oxidoreduction, solving the enigma how tightly bound zinc can be released, re-distributed and 
controlled [44].  The finding challenged the paradigm that zinc proteins are redox-inert and puts zinc 
proteins with zinc thiolate coordination at the crossroad with redox metabolism.  The oxidative 
release of zinc generates a zinc ion signal that can trigger an antioxidant response.  In the simplest 
case and in analogy to reversible thiol/disulfide equilibria in redox biology, a reversible zinc 
thiolate/disulfide transition occurs (Figure 5).  Depending on the agent and the concentrations of 
oxidant involved there can be other thiol modifications and oxidation to higher valence states of 
sulfur, including irreversible oxidation.
Figure 5  Redox activity of zinc thiolate coordination environments.  Zinc dissociates upon oxidation 
of the cysteine sulfur and increases zinc ion availability while reduction decreases availability.  This 
molecular mechanism (shown here for the formation of a disulfide, which is one of many different 
products) couples redox and zinc metabolism.  Zinc thiolate coordination environments serve as 
signal transducers to convert redox signals into zinc ion signals for biological control.  In this way, 
they can also serve as redox sensors to allow redox reactions to control catalytic activity and protein 
structure at sites in or between proteins. 
The common thiol/disulfide redox motif CxxC (C = cysteine) is also a metal-binding motif in some zinc 
finger proteins.  It makes redox motifs liable to zinc inhibition.  It has been discussed that a 
conserved cis-proline precludes metal binding in some proteins of the thioredoxin family, while in 
other proteins, e.g. thioredoxin reductases and glutaredoxins, zinc is a potent inhibitor [45,46].  It is 
a prime example of how specific amino acid signatures have multiple functions: as redox motifs only, 
zinc-inhibited redox motifs, zinc-binding motifs only, or zinc-binding redox switches.  
A theoretical investigation on the reactivity of zinc thiolate complexes with hydrogen peroxide 
concluded that oxidation depends on the type of ligand and decreases in the order CCCC, CCHC, 
CCHH (four, three and two cysteines, respectively; H = histidine) due to a lowering of the 
nucleophilicity of the sulfur ligand donor [47].  Accordingly, the majority of redox-active zinc centers 
are of the tetrathiolate type [48].  Further discussion of the reactivity of various zinc thiolate sites 
can be found in a recent review [49].
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One protein with twenty-eight zinc thiolate interactions is MT.  It will be discussed next because it 
demonstrates how zinc can express antioxidant functions by providing the cell with additional thiols 
as reductants.  Zinc induces the expression of MT, a 60+ amino acid protein with twenty cysteines.  
In addition, it is involved in the biosynthesis of glutathione.  
3.1 Metallothionein: Prototype of a protein linking cellular zinc and redox metabolism 
Metallothionein (MT) binds zinc in two domains in such a way that every zinc ion is surrounded by 
four cysteine sulfurs.  The zinc ions are clustered with three zinc ions bound to nine cysteines in one 
domain and four zinc ions bound to eleven cysteines in the other.  In humans, about a dozen genes 
encode different MTs.  From its discovery in 1957 as a cadmium-containing protein [50], it took at 
least fifty years to understand its role as a zinc protein in zinc metabolism.  The reason for such a 
long quest for a function is that details of how cellular zinc is controlled were not known until 
recently and hence the need for a molecule with the zinc-binding characteristics of MT could not 
have been foreseen.  It is now clear that MT buffers zinc exactly over the range of zinc 
concentrations employed for biological control [51-53].  MT does not have just very tight binding for 
zinc, which would make it a storage protein, but a range of affinities that cover at least two orders of 
magnitude [54].  Furthermore, it is not just one protein but a dozen proteins that all underlie specific 
regulation by many factors including various types of stress, thus adjusting the zinc buffering 
capacity to the demands of the cell [55].
The reactivity of the cysteine thiolates in MT was shown over 30 years ago.  MT reacts with 
superoxide and hydroxyl radicals [56].  Hydrogen peroxide, oxidants such as hypochlorous acid 
(HOCl), selenium compounds, and disulfides react with MT and release zinc ions [57-63].  
Examination of a host of oxidants showed that the redox potential of the thiols in MT is rather low 
and that many biological oxidants can release zinc for transfer to other proteins [42, 64, 65].  Nitric 
oxide also releases zinc from MT in vitro and in cells [66-69].  Another class of agents with zinc-
releasing potential are electrophiles.  Glutathionylated, homocysteinylated, nitrosylated, 
carbonylated, and drug-modified forms of MT have been described [70-74]. 
Zinc release from proteins occurs under pathophysiological conditions such as oxidative and 
carbonyl stress and exposure to drugs and toxicants.  It is a way of how reactive agents interfere 
with zinc metabolism through modification of thiols.  The reactivity with zinc thiolate coordination 
environments in many other proteins has been observed.  Therefore, the effect of reactive species 
on very specific zinc proteins involved in cell biology should not be underestimated.  It has been 
demonstrated that the amount of “free” zinc ions increases with a shift to more oxidizing 
thiol/disulfide conditions [19].  To which extent this redox biology and the redox biology of reactive 
species triggers zinc release from MT and from other proteins with zinc thiolate coordination under 
physiological conditions continues to be an active area of research.
The protein made on the ribosome is thionein (T).  The name metallo-thionein merely signifies its 
association with metal ions.  Whether T can acquire zinc to form MT depends on how much zinc is 
available in the tightly zinc-buffered and zinc-muffled cellular environment.  The protein is not 
always fully saturated with seven zinc ions in cells, suggesting that it should be described in terms of 
an MT/T ratio [75, 76].  It is also not fully reduced as the oxidized protein (thionin) can be detected 
in cells [77, 78].  Structural work showed that thionin is in a disulfide form under oxidative stress 
[79].  The cysteines and their capacity to bind metals ions make the protein both a zinc buffer (MT/T) 
15
and a redox buffer (thionin/thionein) [80].  This property adds a zinc-dependent redox couple to the 
established zinc-independent redox couples in thiol redox biology.  T has the features of an 
intrinsically disordered protein, which can adopt many different structures upon metal binding or 
oxidation, and therefore MT has been referred to as a metamorphic protein [54].  The thiols in T 
have many different orientations and therefore could serve as a sulfur-based chelating agent par 
excellence to remove zinc from its inhibitory sites in proteins [31].  In addition to the redox control 
of the chelating capacity at the protein level, gene expression of T is also tightly controlled via 
multiple signalling pathways, which include redox- and zinc-dependent events and transcription 
factors, fully integrating the redox and metal biochemistry of MT/T into cellular biology.  One 
lingering question is whether MT is merely a buffer for zinc or interacts with other proteins.  The 
biochemical coupling of MT to at least two other redox systems has been observed.  Glutathione is 
one.  Changes in the glutathione/glutathione disulfide couple influence zinc transfer between MT 
and zinc-requiring enzymes [64,82].  Moreover, redox cycling selenium compounds can catalyse such 
a transfer in vitro [83,84].  The other redox system is methionine sulfoxide reductase, for which T can 
serve as a reducing agent [85].  
When MT is described as an antioxidant, a similar ambivalence exists as for zinc.  MT or T may react 
with oxidants and thus be antioxidants but it is a matter of how much oxidized protein (thionin) 
exists under various conditions to serve as an oxidant instead and how much zinc is released with 
either pro-oxidant or pro-antioxidant effects.  
3.2 Proteins with zinc redox switches
Redox activity of zinc thiolate coordination environments in many other prokaryotic and eukaryotic 
proteins has been described and the list of possible candidates amended [43,48].  It introduced zinc 
into the “redox world.”   One needs to distinguish, however, whether high oxidant concentrations 
affect protein functions irreversibly with or without additional adverse effects of the released zinc 
ions or whether genuine regulation of protein function occurs with either reversible zinc binding 
regulating the protein and/or zinc being released for a specific purpose. 
Disruption of protein function in zinc thiolate coordination environments by sulfur modification has 
been demonstrated for catalytic and structural zinc sites, e.g. in subunit interactions of dimeric eNOS 
[86], a voltage-gated K+ channel (Kv4.1) [87], enzyme inactivation [88] or activation [89], and zinc 
finger proteins [90].  The consequences are manyfold: catalysis is affected by ejection of zinc or by 
modification and dissociation of an inhibiting cysteine ligand in the zymogen as in matrix 
metalloproteinases, protein structure controlled, resulting in changed transcription, protein-protein 
interaction interrupted, or ion channel function modulated.  Sulfur modifications occur under 
oxidative stress or increased concentrations of reactive species.  To which extent such reactions are 
a way of physiological regulation in higher organisms is not always entirely clear as discussed in 
themed journal issues [91,92].
Protein kinase C (PKC) is a family of enzymes that are activated by either diacylglycerol or Ca2+, both, 
or neither one, and regulated by phosphorylation, protein degradation, and redox.  Zinc is involved 
in the function of PKCs in different ways.  PKCs have a 2-zinc finger motif (C1 domain) in their 
regulatory domain.  The zinc sites form a zinc redox switch: Oxidants modify the thiolate ligands, 
release the zinc ions, and activate the enzymes by abolishing the autoinhibitory function of the 
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regulatory domain [93,94].  Oxidants have a different effect on the catalytic domain, which they 
inhibit.  More recently, it was demonstrated that high concentrations of zinc inhibit PKCδ, a key 
enzyme in signalling pathways controlling proliferation, differentiation and apoptosis, and interfere 
with its phosphorylation and translocation [95].  Other key signalling Ser/Thr kinases such as Raf-1 
may function with a similar zinc redox switch mechanism [96].  Such a mechanism may also include 
diacylglycerol kinase, which regulates a switch between two different second messengers and their 
signalling.  
After having treated fundamental aspects of zinc biology with regard to redox biology, the article 
continues with how zinc is involved in redox metabolism and its regulation, and what happens if the 
system is perturbed by redox stress, not enough or too much zinc is available, or zinc is added or 
removed.  
4. Zinc in metabolism
The role of zinc in various aspects of metabolism is generally acknowledged [9].  It now seems that 
zinc enzymes are not simply distributed randomly in metabolic pathways and used wherever a need 
for zinc in catalysis arises.  Instead zinc has more specific roles in the control of metabolism and 
other aspects of cell biology, not only as a permanent catalytic and structural cofactor of proteins 
but also in transient interactions with enzymes and proteins that are not zinc metalloproteins.  In 
enzymes, zinc is involved in all six classes defined by the Enzyme Commission.  Bioinformatics 
approaches provided comprehensive lists of human zinc enzymes [15].  In the largest class are 
hydrolases with 397 members, followed by 302 ligases, 167 transferases, 43 oxidoreductases, and 24 
lyases/isomerases.  Proteinases include carboxypeptidases, aminopeptidases, matrix 
metalloproteinases, and peptide hormone processing enzymes/convertases, indicating a wider role 
of zinc in proteostasis.  Hydrolases also include zinc-dependent phosphodiesterases, phospholipases, 
alkaline and acid phosphatases and pyrophosphatases with roles in regulating second messenger 
metabolism and signal transduction pathways.  Zinc is used in DNA and protein (histone) 
modification in demethylases and deacetylases, in DNA and RNA metabolism and DNA repair 
enzymes.  Another significant group of zinc enzymes is involved in regulation: transferases such as 
geranyl and farnesyl transferase, palmitoyl transferases, ligases such as E3 ubiquitin protein ligases, 
SUMO conjugating enzymes, and the corresponding hydrolases.  Zinc is conspicuously absent as a 
permanent cofactor in the enzymes of the main pathways of aerobic and anaerobic energy 
metabolism, perhaps, on a speculative note, an indication of an evolutionary pressure not to have 
these pathways dependent on a micronutrient.  However, zinc may be involved in some aspects of 
regulation of these pathways.  For example, the IC50 values for inhibition of fructose 1,6-
diphosphatase and glyceraldehyde 3-phosphate dehydrogenase are 100 and 150 nM, respectively 
[31].  Zinc inhibits the aconitase-catalyzed conversion of citrate to cis-aconitate with an IC50 value of 
10 nM, which is important for the accumulation of citrate in prostate epithelial cells [97].  Zinc is part 
of the committing enzyme of the pathway of porphyrin biosynthesis, δ-aminolevulinic acid 
dehydratase.  Through its catalytic role in carbonic anhydrases it is involved in the acid-base 
balance/pH control.  Some enzymes, e.g. metalloproteinases and alcohol dehydrogenases, have 
structural zinc sites in addition to their catalytic zinc.  
Furthermore, zinc serves as a brace in subunit interactions and in structural sites for organizing 
protein architecture and interactions.  Coupling some of these sites with zinc thiolate coordination 
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to redox reactions and the dependence of the interactions on zinc concentrations suggests that 
occupancy of zinc sites is a way of influencing, and maybe regulating, protein conformational 
landscapes and part of the interactome. 
The following selected examples will discuss roles of zinc in some pathways related to redox 
metabolism.  Which proteins are affected when zinc concentrations change or become limiting is 
difficult to pinpoint as there are so many targets in addition to zinc-dependent regulation of the 
proteins at the transcriptional, translational and posttranscriptional levels.  
4.1. Zinc in coenzyme metabolism
The pterin cofactor pathway leading to tetrahydropterin (BH4), the molybdopterin cofactor, and 
pteridine in folate/tetrahydrofolate (THF) contains zinc-dependent enzymes.  The enzyme initiating 
the pathway from GTP, cGMP cyclohydrolase I, is a zinc enzyme and the second enzyme, 6-pyruvoyl-
tetrahydrobiopterin synthase is also a zinc enzyme.  BH4 is needed for the aromatic amino acid 
hydroxylases in monoamine neurotransmitter biosynthesis and in nitric oxide synthase (NOS).
Pyridoxal kinase and riboflavin kinase, controlling cofactor biosynthesis, prefer a Zn-ATP over a Mg-
ATP complex [98].  X-ray structures of these enzymes show the binding of a Zn-ATP complex [99, 
100].  The preference for Zn-ATP has also been measured for NAD kinase, which forms NADP+ from 
NAD+ [101].  
Zinc is involved in other aspects of the metabolism of NAD+/NADH, which has been called the redox 
currency of the cell [102].  Mammalian alcohol dehydrogenases are a family of zinc enzymes that use 
NAD+/NADH as a cofactor.  It includes sorbitol dehydrogenase, which is one of two enzymes in the 
polyol pathway that performs a transhydrogenation from NADPH to NADH, and, when activated, 
depletes NADPH and NAD+.
Sirtuins are directly coupled to the energy status of the cell.  They are NAD+-dependent mono-ADP 
ribosyltransferases, deacetylases of histones, and have hydrolase activity with a wide array of 
functions.  In addition to having a structural zinc sites, sirtuin1 is strongly zinc-inhibited (IC50 = 0.26 
nM) [103].  Poly (ADP-ribose) polymerases (PARPs) are signalling enzymes in NAD+ metabolism.  They 
also use NAD+ and have a 2-zinc finger motif in their DNA binding domain.
4.2. Zinc in the activated methyl cycle/transsulfuration pathway
In the activated methyl cycle/transsulfuration pathway, zinc has a role in several enzymes (Figure 6) 
[104].  Betaine-homocysteine methyltransferase and methionine synthase are zinc enzymes.  Both 
enzymes synthesize methionine to provide the cofactor S-adenosylmethionine (SAM) for biological 
methylations.  Here again, it is not only the role of zinc in enzymes but also its role in cofactor 
metabolism and control of enzymes such as cystathionine β-synthase and serine 
hydroxymethyltransferase by zinc-dependent transcription factors.  Adenosine deaminase and 
guanine deaminase are zinc enzymes forming inosine (hypoxanthine) and xanthine, respectively in 
the degradation pathway of purine and purine nucleosides leading to uric acid, which is a scavenger 
for free radicals.  
The immediate health implications of the involvement of zinc in the activated methyl cycle are 
evident with regard to elevated serum homocysteine concentrations as a risk factor for 
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cardiovascular diseases.  Serum homocysteine concentrations are significantly higher in zinc-
deficient rats, but zinc supplementation has no effect on this increase [105].  
Figure 6   Zinc in the activated methyl cycle/transsulfuration pathway, a critical branching point in 
metabolism connecting sulfur metabolism, cofactor chemistries, and biological methylations.  SAM, 
S-adenosylmethionine, SAH, S-adenosylhomosysteine, HCys, homocysteine, Cys, cysteine.  Enzymes: 
1, methionine synthase (MS), zinc enzyme; 2, betaine homocysteine methyltransferase (BHMT), zinc 
enzyme; 3, methionine adenosyltransferase; 4, N-glycine methyltransferase; 5, SAH hydrolase; 6, 
cystathionine β-synthetase (CBS), regulated by zinc-dependent transcription factors; 7, γ-
glutamylcysteine synthetase (glutamate cysteine ligase, GCL), regulated by zinc-dependent 
transcription factors; 8, methylenetetrahydrofolate reductase; 9, serine hydroxymethyltransferase 
(SHMT), regulated by zinc-dependent transcription factors.  Additional zinc enzymes are histone and 
DNA methyltransferases and adenosine deaminase.  Coenzymes: folate: 5-methyltetrahydrofolate 
(5-MTHF): reaction 1; 5,10-MTHF: reaction 8; THF: reaction 9; B12: reaction 1; B6: reactions 6 and 9; 
riboflavin participates in several reactions.    
The second aspect of this cycle is that it controls cysteine and glutathione biosynthesis in the 
transsulfuration pathway.  Remarkably, as with MT, zinc and redox regulation converge in 
glutathione biosynthesis and function.  Glutamate cysteine ligase (GCL) is the first, rate-limiting step 
of glutathione biosynthesis, synthesizing γ-glutamylcysteine from Glu and Cys using ATP.  It has two 
subunits, a catalytic subunit (GCLC), which is active alone, and a modifier subunit (GCLM) which 
increases the activity of the catalytic subunit.  GCLC and GLCM are under control of the transcription 
factor Nrf-2 (see below).  Remarkably, while GCLC is a target of MTF-1-directed gene expression in 
mice, investigations with primary rat endothelial cells showed that the effect of zinc on GCL 
synthesis does not depend on MTF-1 [23, 106].  Like MT, glutathione is involved in the interaction of 
metal ions such as copper and zinc ions and participates in either loading zinc into proteins or zinc 
transfer between proteins [64, 107, 108].
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And a third aspect is that zinc is a cofactor in glutathione-dependent enzymes in the metabolism of 
reactive species.  Alcohol dehydrogenase 5 (class III ADH) reduces formaldehyde in the form of S-
formylglutathione and is also an S-nitrosoglutathione dehydrogenase [109, 110].  Both glyoxalase I, 
forming S-2-hydroxyacylglutathione from 2-oxoaldehdyes and glutathione, e.g. S-D-
lactoylglutathione from methylglyoxal, and glyoxylase II, which cleaves the thioester, are zinc-
containing enzymes in the detoxification of reactive carbonyls. 
4.3 Zinc in nitric oxide metabolism
Zinc has a role in reactions that link the urea cycle and NO production.  Nω-methyl- (L-NMMA) and 
Nω,Nω-dimethyl-L-arginine (ADMA) inhibit neuronal nitric oxide synthase (nNOS).  The enzyme that 
regulates these inhibitors is dimethylarginine dimethylaminohydrolase (DDAH-1), which forms L-
citrulline and mono- or dimethylamine.  The enzyme is under the control of the zinc-sensing 
transcription factor MTF-1 and is inhibited by zinc binding to the active site with a Ki of 4.2 nM [111, 
112].  DDAH-2 is the product of another gene and found in tissues expressing eNOS.  NOS itself 
requires zinc for its dimerization, which is interrupted by oxidative modification of the tetrathiolate 
zinc site (see above).  nNOS is inhibited by zinc, but the apparent Ki is only 30 µM [113].  
5 Zinc dose-response relationship
Homeostatic mechanisms use sensors that detect imbalances and initiate a programme to restore 
the steady-state.  The sensor for an increase of cellular zinc ion concentrations is MTF-1.  The sensor 
for a decrease of cellular zinc ion concentrations is not known for mammalian systems.  In the 
following section, three ranges will be considered to discuss the effects of zinc on redox metabolism: 
not enough zinc (zinc deficiency), normal zinc status, and too much zinc (zinc overload).  Imbalances 
can develop as a result of oxidative stress, genetic factors, nutrition, drugs or other agents that bind 
zinc, or supplementation with too much zinc.  Generally, the pro-oxidant effects can be cytotoxic, 
pro-inflammatory and pro-apoptotic while the pro-antioxidant effects can be cytoprotective, anti-
inflammatory, and anti-apoptotic [114].  
When quantitative PCR, cDNA array and proteome technologies became available, the effect of zinc 
on gene expression was examined by increasing or decreasing zinc available to cultured cells.  
Nutritional zinc deficiency in rodents affected intestinal mRNA levels of MT-1, zinc transporter 2, 
uroguanylin, and iNOS as well as mRNAs of genes involved in signalling pathways, growth, 
transcription, redox and energy utilization [115, 116].  In the human colon cancer cell line HT-29, 
lower intracellular zinc caused changes in the mRNA levels of 309 genes [117].  The transcripts 
encode proteins in intermediary metabolism (79) including protein metabolism (21), signalling (30), 
cell cycle control and growth (15), vesicular trafficking (15), cell-cell interactions (13), cytoskeleton 
(10) and transcriptional control (19).  Higher intracellular zinc impaired ATP synthesis and cell cycle 
control and induced proteins involved in the stress response [118].  Another global analysis of the 
effects of zinc deprivation and excess on human monocytic/macrophage THP-1 cells demonstrated 
that 5% of 1,045 genes investigated were zinc-responsive [119].  In addition to zinc-dependent gene 
transcription, there are numerous effects on cellular functions that do not depend on de novo 
synthesis of proteins.
5.1 Zinc deficiency, a pro-oxidant condition causing oxidative stress
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The effect of zinc deficiency on growth of Aspergillus niger was reported in 1869 by Jules Raulin, a 
student of Louis Pasteur [120].  Evidence for zinc deficiency in humans was gathered only in 1963 
[8].  Over these hundred years, it became established that zinc is needed for the growth and 
development of all species.  The involvement of zinc in a myriad of proteins provides a basis of why 
zinc deficiency affects so many physiological functions.  
A hallmark of zinc deficiency is oxidative stress.  The primary cause for the oxidative stress and the 
chain of biochemical events in zinc deficiency is not entirely clear.  General features, however, have 
been established.  Overall, consequences of zinc deficiency are an inability to launch an antioxidant 
defence, which at least in part depends on zinc as shown for hydrogen peroxide [121], generation of 
endoplasmic reticulum (ER) stress, an inflammatory response, and an effect on cellular calcium. 
In zinc-deficient rodents, the function of calcium channels in the plasma membrane is compromised, 
perhaps due to changes of the redox state of critical thiols, leading to a reduction in calcium uptake 
[122].  Depleting extracellular zinc results in a rapid transient mobilization of intracellular “free” zinc 
ions [123].  A change of the thiol/disulfide redox state to more oxidizing conditions also increases 
cellular “free” zinc ion concentrations [77].  Zinc inhibits the plasma membrane Ca2+-ATPase, which 
controls cellular free calcium concentrations, with a Ki of 80 pM [124].  Indeed, zinc deficiency in 
animals depresses Ca2+-ATPase activity in erythrocyte membranes [125].  Also, an increase of cellular 
“free” zinc ions to concentration >2 nM, as observed in ischemia, leads to calcium leakage from the 
cardiac redox-sensitive ryanodine receptor/calcium channel (RyR2) [126].  The increase of cellular 
calcium activates NADPH oxidase and NOS and results in the production of reactive species.  
Extracellular zinc deprivation also activates the production or reactive species by NADPH oxidase and 
NOS [127, 128].  Zinc, together with copper, is a cofactor of the active site of superoxide dismutases 
1 and 3.  Under zinc deficiency, SOD undergoes a conformational change that makes the interaction 
with the protein Derlin possible and activates the ER stress response [129].  Taken together, these 
results delineate a plausible pathway how less available extracellular zinc affects intracellular 
interactions between zinc and calcium metabolism and causes oxidative stress. 
Zinc protects isolated lysosomal and microsomal preparations from lipid peroxidation [130, 131].  
Subsequently, it was shown that zinc deficiency leads to membrane damage in isolated organelles 
[132], protein and DNA damage in isolated cells in addition to its effects on lipid peroxidation [133, 
134], and changes in signal transduction pathways that determine both cell fate and protection of 
cells against stress [135].  All of these effects are due to zinc deficiency eliciting an oxidative stress in 
cultured cells [136].  And finally, it was confirmed that markers of oxidative stress increase under 
suboptimal zinc intake in humans [137-139].  Because of its DNA damaging effects and the role of 
zinc in DNA repair, zinc deficiency was discussed as having a role in carcinogenesis [140].  Work on 
esophageal squamous cell carcinoma demonstrated that zinc deficiency is a risk factor.  Zinc 
deficiency causes an inflammation with a dose-dependent up-regulation of oncogenic mi-RNA [141].
When reviewing the oxidative stress in zinc deficiency, the role of the transcription factor Zap1 as a 
sensor of low zinc status in yeast was discussed [142].  Among the about 80 genes induced is TSA1, a 
peroxiredoxin that reduces hydrogen peroxide to water through reactions coupled to thioredoxin, 
thioredoxin reductase and NADPH.  Zap1 is also involved in controlling genes that are needed for 
sulfur assimilation in yeast with an additional posttranslational control of these proteins that are 
involved in providing methionine and cysteine in an NADPH-dependent pathway.  Under zinc-
21
limiting conditions, the levels of these sulfur amino acids decrease.  This situation is reminiscent of 
the role of zinc in the antioxidant response and the transsulfuration pathway in humans (see above).  
However, a transcription factor such as Zap1 in yeast is not known to exist in humans.  Oxidative 
stress sensing seems to be involved in detecting low zinc concentrations with a transcriptional 
response controlled by MTF-1 and Nrf-2 (see below).   
Further investigations with the yeast model began to address the effects of zinc deficiency on the 
zinc proteome.  They showed that transcriptional regulation results in a lower abundance of zinc 
proteins and that many zinc enzymes are made but not metalated or perhaps mis-metalated [143].  
It remains unknown whether kinetic or thermodynamic factors determine the re-distribution of zinc 
and whether a functional hierarchy exists and is managed by a triage process that prioritizes the 
allocation of zinc.  A triage hypothesis has been proposed for the systemic control of micronutrients.  
It distinguishes allocation to proteins necessary for immediate survival and reproduction from that 
to proteins important for long-term health [144].
In summary, minimally there are two pathways for generating oxidative stress in zinc deficiency, a 
direct pathway mediated through an effect on calcium metabolism and an indirect pathway limiting 
the antioxidant response.  One would assume that the regulatory functions of zinc cease first under 
zinc deficiency.  It is supported by the observation that cells stop growing and differentiating.  If zinc 
is further restricted, proteins will not obtain their structural and catalytic zinc for function.  In 
addition, oxidative stress will interfere with their functions.  When added under pro-oxidant 
condition of zinc deficiency zinc will have antioxidant-like functions.  However, whether homeostatic 
control of zinc can be completely restored will depend on whether the oxidative stress, which can 
originate from zinc-independent pathways, can be controlled and redox homeostasis be restored.
A consequence of low zinc and the associated oxidative stress is systemic chronic inflammation and 
eventually cell death.  One of the first signs of zinc deficiency is a compromised immunity.  Both 
innate and adaptive immunity depend on zinc in many different ways [145].
5.1.1. Zinc and inflammation
Inflammation is a response of the host to pathogens or injury.  A component of it is the acute phase 
response as a result of stress or infection.  It lowers the zinc concentration in the blood.  Acute and 
chronic inflammation is associated with additional changes in zinc metabolism.  Activation of Toll-
like receptors on immune cells or the tumor necrosis factor α (TNF α) receptor on other cell types 
results in signal transduction to the transcription factor NF-κB (nuclear factor kappa-light-chain-
enhancer of activated B cells), which controls the production of cytokines and the survival of cells.  
Signalling to NF-κB is zinc-dependent [146].  An examination of the NF-κB signalling pathway 
revealed the involvement of zinc in at least 25 sites of different proteins (TRAF2, A20, Tab2/3, 
TAX1BP1, Nup475/TTP/Tis11, IKKγ/Nemo, RNF11 [114].  This observation epitomizes the prevalence 
of zinc in signalling pathways and hence the issue how difficult it is to pin-point which site(s) will be 
affected by zinc deficiency primarily or which proteins zinc regulates in this or any other signalling 
pathway.  Zinc deficiency has a pro-inflammatory effect while optimal zinc concentrations suppress 
the inflammatory response.  In humans, inflammatory cytokines increase in zinc deficiency.  Thus, in 
addition to zinc being a constituent of the proteins in the NF-κB signalling pathway, it can be 
involved in the regulation of proteins at various levels.  A transcriptional target of NF-κB is the zinc 
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transporter Zip8 which transports zinc into the cell and modulates IκB kinase reversibly to trigger an 
anti-inflammatory response [147].
These findings are also highly significant for endothelial dysfunction and the involvement of zinc in 
the inflammatory process and ensuing vascular disease [148].  Zinc deficiency in vascular endothelial 
cells increases the binding of NF-κB to DNA, induces expression of cyclooxygenase-2 and E-selectin 
and affects monocyte adhesion [149].  Transactivation of peroxisome proliferator-activated receptor 
(PPARγ), which inhibits NF-κB/DNA binding, requires zinc.  Therefore, under zinc deficiency there is 
no inhibitory action and inflammatory cytokines are produced [150].  PPARs belong to the nuclear 
hormone receptor family which have two tetrathiolate zinc fingers, which themselves are sensitive 
to oxidative stress.  These interactions also demonstrate that zinc status can be critically important 
for drug action.  Rosiglitazone is an agonist for PPARγ.  Under zinc deficiency the drug is expected 
not to work properly [149].  
5.1.2. Zinc and cell death
Zinc is involved in cell fate decisions [151].  Zinc is needed for cell growth, and without enough zinc, 
there is cell cycle arrest at G1/S and G2/M checkpoints.  From both checkpoints zinc deficiency can 
cause apoptosis, which normally is suppressed by a balanced zinc status [152].  There is significant 
insight into how zinc deficiency causes apoptosis.  Forty years ago, it was noted that zinc deficiency 
in rodents leads to apoptosis in the small intestine and in the thymus, resulting in an 
immunodeficiency [153, 154].  Zinc deficiency in rodents accelerates apoptosis among pre-T cells 
and pre-B-cells [155].  In zinc-deficient mice, a chronic elevation of glucocorticoids (corticosterone), 
which can be prevented by adrenalectomy, was observed and it was demonstrated that zinc 
deficiency is a condition of stress [156,157].  Glucocorticoid receptors also belong to the nuclear 
hormone receptors with two tetrathiolate zinc fingers sensitive to oxidative stress.  In epithelial cells 
of fish gill cells, cortisol increases the uptake of zinc, the increase of “free” zinc ion concentrations 
and the MTF-1-dependent expression of ZnT-1 and two MTs [158].  Glucocorticoids also affect 
cognitive functions.  It has been discussed how the increased levels of glucocorticoids under zinc 
deficiency alter brain functions associated with zinc signalling [159].
Caspase-3 is activated in zinc-deficient cells and in rat embryos [160, 161].  Zinc was found to inhibit 
caspase 3 with an IC50 value of 0.15 µM [162], but later the IC50 was determined to be as low as 10 
nM [31], suggesting that the inhibitory zinc must be removed to initiate apoptosis.  
A remarkable structural basis with complex regulation of caspases has now been established, indeed 
confirming zinc binding and the need for activation by removal of the inhibitory zinc in some 
caspases [163].  Caspases-3, -6, and -8 are inhibited at cellular zinc ion concentrations (2.6-6.9 nM) 
whereas inhibition of caspase-7 is weaker (76 nM).  Capase-3, -7 and -8 bind three, one and two zinc 
ions, respectively, at the active site, while zinc inhibits caspase-6 allosterically.  Caspase-8 is inhibited 
at the active site but also at a second site, inhibiting the formation of the active dimer.  The example 
of caspases shows how zinc inhibition employs different strategies and affinities for regulation.
Structural zinc sites are also found in inhibitor of apoptosis proteins (IAPs) and BAK (BCL-2-
antagonist/killer 1), a pre-apoptotic protein from the BCL-2 (B-cell lymphoma 2) family of proteins 
that are needed to permeabilize the outer mitochondrial membrane to release apoptotic factors in 
the intrinsic pathway of apoptosis.  For instance, XIAP (IAP3/BIRC3) has a BIR (Baculovirus Inhibitor 
23
of apoptosis protein Repeat) domain with a 3Cys/1His binding site and controls caspases -3, -7, and -
9.  It also has a RING zinc finger domain involved in ubiquitination of caspases.  The BAK homodimer 
binds a zinc ion at its dimer interface [164].   
The tumour suppressor p53 is a cellular guardian that detects DNA damage and potentially 
damaging stress, including oxidative stress, and decides between a DNA repair programme and cell 
cycle arrest and apoptosis.  It is a transcription factor with a zinc thiolate coordination site in the 
transactivating domain.  It is controlled by interaction with MDM2 (mouse double minute 2 
homologue), which is a U3 ubiquitin ligase with a RING zinc finger and blocks the transactivating 
domain of p53. 
A major review article discusses the molecular events pertinent to redox signalling under zinc 
deficiency as investigated in rodents and in cultured cells [165].  The effects mirror many of the 
observations made when the zinc levels are too high, indicating the same signalling pathways and 
the role of zinc in controlling the phosphorylation of proteins.  But there are also differences.   One 
important observation in this regard is a deficit in microtubule assembly under zinc deficiency and 
consequently disrupted cytoplasm-nucleus shuttling of transcription factors [166].   
In rats with maternal marginal zinc deficiency and in the IMR-32 neuroblastoma cell line grown 
under zinc-limited conditions, JAK(Janus kinase)/STAT (signal transducer and activator of 
transcription) signalling is affected, in particular a reduced tyrosine phosphorylation of STAT1 and 
STAT3 and hence less transactivation.  α-Lipoic acid prevents the reduced phosphorylation of STAT1 
but not STAT3, perhaps indicating differential effects of redox and zinc modulation of protein 
tyrosine phosphatases [167].
There is a considerable literature linking zinc and caspase-independent cell death involving 
lysosomes and autophagy [168].  In addition to the many zinc transporters coordinating subcellular 
zinc traffic, other membrane transporters also are involved in translocating zinc ions.  There is 
oxidative release of zinc from lysosomes through TRPM2 (transient receptor potential cation channel 
subfamily M, member 2) leading to pancreatic β-cell death [169].  TRPM7 is located on a novel type 
of vesicle, M7V.  It is distinct from endosomes, lysosomes or other vesicles, stores only zinc and 
glutathione, and releases its contents as a function of oxidation [170].  Unrelated to these findings 
on cellular organelles, another channel from this family, TRPA1 (subfamily A, member 1), is activated 
by zinc ions with an EC50 value of 7.5 nM and serves as an intracellular sensor for zinc in dorsal root 
ganglia neurons [171].  Similar findings were reported for the same somatosensory receptor in other 
tissues, requiring zinc influx through the channel and activation by zinc intracellularly [172].
The state of zinc in lysosomes and zinc-mediated autophagy is important for both zinc deficiency and 
zinc overload (see below).  Thus, it is a matter of whether an oxidative stress comes first and triggers 
zinc release or a zinc stress comes first and triggers an oxidative stress.  Under conditions of 
oxidative stress, zinc concentrations increase in lysosomes, presumably as a result of zinc being 
released from proteins such as MTs, inducing lysosomal dysfunction by membrane permeabilization 
and autophagy [173].  One major pathway of zinc-induced apoptosis is the activation of PARPs, a 
process which uses relatively large amounts of NAD+, which then leads to a decrease in ATP 
production.
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Another compartment that is discussed regarding zinc deficiency and zinc overload is the ER where 
not enough or too much zinc cause protein misfolding and the unfolded protein response (UPR), 
signalling ER stress. 
5.2 Zinc as a pro-antioxidant
Two different conditions can be distinguished.  First, the physiological zinc concentrations already 
present counteracting pro-oxidant conditions by inducing an antioxidant response, in which case 
zinc acts as a pro-antioxidant.  And second, the effect of supplemented zinc or zinc added to cultured 
cells, which can protect against an insult/stressor.  There is no evidence that zinc ion signals are used 
to generate a pro-oxidant redox signal under physiological conditions.
An “antioxidant paradox” was noted on the ground that dietary zinc does not have the same actions 
as cellular zinc [174].  The argument is based on the fact that extra zinc in the diet (3-10 x 
recommended daily allowance, RDA of 15 mg for males 11-50 years of age) competes with copper 
uptake, reducing the activity of erythrocyte Cu,Zn-SOD in humans and liver and heart Cu,Zn-SOD in 
animals and thus has a pro-oxidant effect.  On the other hand, an antioxidant role is believed to be 
due to an increase of the zinc-MT pool.  Another article entitled “Why zinc should not be considered 
an antioxidant” points out that zinc is also a selenium antagonist, abolishing its anticarcinogenic 
effects and that additional zinc in the diet may be linked to an increase in skin cancer and that 
additional zinc in healthy human breast tissue increased the risk of later breast cancer development 
[175].  A similar observation was made for prostate cancer where the risk increased slightly when 2.5 
times the recommended tolerable upper limit of 40 mg was supplemented in trials to prevent age-
related macular degeneration [176].  
Three mechanisms have been adduced to explain the pro-antioxidant functions of zinc: a) protection 
of free sulfhydryls, b) out-competing redox-active metal ions, and c) specific induction of an 
antioxidant response.  The first two do not seem to explain antioxidant-like function because zinc 
thiolates are redox active and zinc binds to the active site of antioxidant thiol enzymes and inhibits 
them.  Also, too much zinc can induce a copper deficiency, which results in a pro-oxidant response 
due to the need for copper in SOD.  But there are also processes that, with or without 
supplementing zinc, make more “free” zinc ions available in the cell, e.g. processes that affect 
cellular zinc homeostasis and metal buffering, engendering a pro-antioxidant effect.  For example, 
“free” zinc ion concentrations transiently increase in preconditioning of cortical neurons.  The 
excitotoxic tolerance associated with this preconditioning involves PKC-induced phosphorylation of 
MT and modulation of gene expression [177].  Thus, for the third mechanism there is clear evidence 
in two pathways.
MTF1.  The transcription factor MTF-1 binds to an MRE (metal response element) in a zinc-
dependent way.  It has six zinc fingers which are thought to participate in the zinc-sensing 
mechanism in addition to a metal-responsive activation domain.  MTF-1 is part of a stress response 
to heavy metals, hypoxia and oxidative stress, maintenance of cellular zinc homeostasis by induction 
of MT and ZnT1, and it is essential for embryonic liver development [23].  Various stressors such as 
cadmium or oxidants react with MT and release zinc, which then activates MTF-1.  In this way, MT 
has an indirect effect on metal metabolism as an “antioxidant.”  Other important genes induced by 
zinc activation of MTF-1 are involved directly in redox metabolism: selenoprotein W (basal 
expression), a protein involved in growth, differentiation, and protection from oxidative stress; 
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selenoprotein H (repressed), a nuclear oxidoreductase with functions in carcinogenesis and 
mitochondria, and in suppressing senescence; thioredoxin reductase-2 (repressed), a mitochondrial 
form of the enzyme, scavenging reactive oxygen; GCLC (heavy chain, basal expression); placental 
growth factor, which is hypoxia-induced; dimethylarginine dimethylaminohydrolase, involved in NO 
metabolism as stated above; α-fetoprotein, a fetal analogue of serum albumin, which is a zinc 
binding protein (both basal expression); enhancer protein C/EBPα, a protein involved in liver 
development; C-reactive protein (CRP) which has LIM zinc-binding domains; and KLF4, a zinc finger 
protein involved in many fundamental processes.    
Nrf-2 (nuclear factor erythroid 2-related factor 2).  The transcription factor Nrf-2 binds to an ARE 
(antioxidant response element).  Among the genes induced are NAD(P)H: quinone oxidoreductase 1, 
heme oxygenase 1, and enzymes in the antioxidant defence such as glutathione peroxidase 2, 
peroxiredoxin 1, thioredoxin and thioredoxin reductase, and GCL.  Nrf-2 interacts with Keap1 (Kelch-
like ECH associated protein-1), which keeps Nrf-2 inactive and ready for proteosomal degradation.  
Keap1 is a sensor for electrophiles.  The sensing leads to dissociation and activation of Nrf-2 
transcriptional activity stimulated by PKC.  It has been postulated that a zinc tetrathiolate site is 
involved in sensing electrophiles [178].  It was also suggested that Nrf2 is a sensor for zinc when 
employing residues His-225, Cys-226 and Cys-613 for zinc binding.  In order to demonstrate this zinc 
sensor function, which involves a conformational switch associated with zinc binding, cultured cells 
were exposed to relatively high, micromolar concentrations of zinc ions [179, 180].  
Many investigations have shown that supplemental zinc protects against stress injury in organs such 
as the liver and the heart.  In the elderly, zinc supplementation improves markers of oxidative stress 
and inflammation [139].  The main mechanism underlying these observations seems to be the 
antioxidant defence induced via these two transcription factors.
In summary, zinc is involved in controlling reactive species and the antioxidant response under 
physiological concentrations and this function can be enhanced by additional zinc under some 
conditions.
5.3  Zinc overload: A pro-oxidant condition
If the discussion was challenging which processes, governed by an estimated 3000 zinc proteins, are 
affected in zinc deficiency, a corresponding discussion what happens when cellular zinc 
concentrations increase is even more daunting.  As zinc ion concentrations increase more 
interactions become possible.  The consequences depend on the zinc buffering and muffling 
capacities of cells, which likely differ in cells depending on the variable expression of MTs and zinc 
transporters.  Zinc interacts strongly with proteins and, if not properly controlled, the lack or a 
surplus of zinc can cause protein misfolding and aggregation.    
In stark contrast to zinc not being very toxic systemically, it is relatively toxic for cells when 
unbuffered and released intracellularly.  For investigations with cultured cells, it is important to 
consider that normal zinc concentrations in blood are about 15 µM and buffered and even lower in 
the extracellular fluid (about 5 µM).  Serum-free media have very little buffering capacity and except 
for F-12 medium do not contain added zinc.  Accordingly, toxicity to cells can be detected at 
concentrations as low as 20 µM added zinc, whereas zinc concentration > 100 µM become toxic in 
media with 5-10% serum [181].  If agents are present that serve as ionophores, toxicity is expressed 
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at much lower concentrations.  Thus, thymocytes cultured in the presence of 10% serum undergo 
apoptosis when exposed to only a few hundred nanomolar zinc pyrithione [182].  The scientific 
literature is replete with experiments performed at much higher, occasionally even millimolar, 
concentrations of zinc.  HeLa cells can adapt to high zinc concentrations (200 µM) and become 
resistant to zinc [183].  They express more MT and consequently become more resistant to oxidative 
stress.  Other differentially expressed proteins in these adapted cells include cochaperones, 
oxidoreductases, and ubiquitin [184].
The term “zinc overload” is not well established.  It can refer to i) zinc supplemented at high doses 
(>100 mg/day), notwithstanding that supplementation at much lower doses in a healthy individual 
can have adverse effects by reducing copper and iron uptake, ii) increases of cellular “free” zinc ion 
concentrations if the buffering and muffling capacities are exhausted or challenged by other means 
such as exposure to toxic metal ions, and iii) genetically determined conditions.  For example, cases 
of unusually high serum zinc concentrations have been reported.  One condition is due to 
calprotectinemia, elevation of a protein of the S100 family, the expression of which is controlled by 
zinc in myeloid cell lines [185, 186].  Investigations in two areas influenced our knowledge about zinc 
as a cellular toxin: exposure of the lung to inhaled zinc-polluted air and intrinsic dislocation of zinc 
ions damaging neurons in the brain.
Occupational and environmental exposure to zinc-containing particles through inhalation can result 
in supraphysiological zinc ion levels that activate gene expression to mount a defence and an 
inflammatory response and that cause oxidant conditions through the production of reactive species 
and concomitant changes of the glutathione/glutathione disulfide ratio.  Mitochondrial dysfunction 
and modulation of the mitochondrial permeability transition pore eventually lead to cell death 
signalling [187].  In substantial contributions from the authors in publications summarized in their 
review, the effects of zinc were mapped to several pathways.  Zinc activates mitogen-activated 
protein kinase (MAPK)-dependent pathways: JNK (c-Jun-terminal kinase)/p38, and ERK (extracellular 
signalling kinase).  Zinc affects the epidermal growth factor receptor (EGFR) pathway that also 
activates NADPH oxidase.  Interleukin-8 (IL-8), a neutrophil chemotactic factor, cyclooxygenase-2, 
and heme oxygenase (HO-1) increase through activation of Keap-1/NF-кB dependent transcription in 
human airway epithelial cells.  Central to these events is an effect of zinc on phosphorylation 
signalling.  In addition to effects of zinc on kinases, zinc inhibition of protein tyrosine phosphatase 1B 
was demonstrated [188, 189].
Work on how zinc affects the developing central nervous system and what roles it has in the injured 
and inflamed brain and in neurodegeneration is even more prolific and covered by many extensive 
reviews [190-192].  Initially, calcium overload was shown to be the link between glutamate 
excitotoxicity and neurodegeneration in ischemia.  But then zinc was discussed as the downstream 
mediator of the damage with mitochondrial dysfunction as having a major role [193].  Some neurons 
have zinc-rich vesicles (boutons) in their synaptic terminals and use zinc for neurotransmission.  
Regional differences in the sources of zinc ions and their interactions with mitochondria in neurons 
exist and underlie differential vulnerability in diseases [194].  Activated microglia are a source of 
reactive species, which can increase “free” zinc ions in neurons.  As a consequence of the increases 
in cellular zinc ions, potassium efflux occcurs and leads to neuronal death [195].  A decline in ATP 
production due to a decrease in NAD+ via zinc inhibition of glyceraldehyde phosphate 
dehydrogenase  and PARP activation contributes to cell death [196].  In essence, an increases of 
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cellular “free” zinc ions downstream of increased cellular calcium is a major contributor to neuronal 
death (Figure 7).  Activation of NADPH oxidase, NOS, and release of zinc ions from proteins such as 
MT, and perhaps from organelles, and zinc inhibition of the mitochondrial respiratory chain and 
ensuing generation of reactive species are the major factors in causing cell death [197, 198].  
Pathways involving phospholipase A2 and lipoxygenase or xanthine oxidase have been discussed as a 
source of reactive species in some cells.
Lysosomes, the ER and mitochondria contribute to cell death when zinc homeostasis is perturbed.  
Under conditions of oxidative stress, zinc concentrations increase in lysosomes, presumably as a 
result of zinc released from proteins such as MT and induce lysosomal dysfunction by membrane 
permeabilization and autophagy [199].
Last but not least, the role of zinc in mitochondrial function will be addressed briefly.  The role of 
mitochondria in energy metabolism, production of reactive species, and apoptosis is highly 
significant for conditions of zinc overload.  What happens to mitochondrial function in zinc 
deficiency and whether zinc modulates mitochondrial function under normal physiological 
conditions needs further exploration.  Zinc is a constituent of some of the protein complexes of the 
respiratory chain.  It also inhibits mitochondrial respiration by interacting with sites in complexes I 
and III [200, 201].  Complex I has a zinc site but the binding is rather weak with a dissociation 
constant of about 10-50 µM [202].  Zinc also interacts with His-503 in bovine cytochrome c oxidase 
(complex IV) and inhibits proton pumping [203].  MT carries zinc through the mitochondrial outer 
membrane and releases zinc in the intermembrane space.  The released zinc then inhibits the 
respiratory chain, decreases ATP synthesis and increases the production of reactive oxygen, affecting 
the mitochondrial permeability transition pore and releasing apoptotic factors [204-206].  Zinc 
inhibition of mitochondrial respiration (α-ketoglutarate supported) affects the lipoamide 
dehydrogenase reaction of the α-ketoglutarate dehydrogenase complex with a Ki of about 150 nM, 
activating the NADH oxidase reaction and leading to hydrogen peroxide and superoxide formation 
with an activation constant of about 90 nM [207].  
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Figure 7  The role of zinc in neurotoxicity.  Calcium entry into neurons activates iNOS for the 
production of nitric oxide (NO) and at least three additional pathways, phospholipase A2 (PLA2), 
NADPH oxidase, and xanthine oxidase (XO) for the production of superoxide (O2-).  The NO and O2- 
radicals combine to form peroxynitrite (ONOO-).  The reactive species affect metallothionein (MT), 
thiol/disulfide buffering of thionein (Tred) and thionin (Tox) and other thiol/disulfides such as 
glutathione/glutathione disulfide and increase the concentrations of “free” zinc ions that inhibit 
mitochondrial respiration, decrease ATP synthesis, and increase the production of reactive species.
6 Implications for the life course. Diseases and healthy ageing
The relationship between redox and zinc biology has enormous implications for understanding 
cellular biology in health and disease.  As discussed in this article, zinc deficiency causes oxidative 
stress and oxidative stress inevitably affects cellular zinc metabolism.  Oxidative stress can lead to a 
loss of zinc and possibly zinc deficiency, which then exacerbates oxidative stress and initiates a 
vicious circle.  Thus, all conditions associated with oxidative stress, i.e. atherosclerosis and 
cardiovascular disease, obesity and diabetes, ischemia-reperfusion, cystic fibrosis and other fibrotic 
processes, rheumatoid arthritis and inflammation of other organs such as the liver, brain and lung 
(chronic obstructive pulmonary disease, COPD), cancer, and brain conditions such as 
ischemia/stroke, traumatic injury, neurodegenerative diseases (Parkinson and Alzheimer disease), 
amyotrophic lateral sclerosis, microbial and viral infections [3], need to be considered with regard to 
the consequences for zinc metabolism and a role of zinc in pathogenesis.  In addition, conditioned 
zinc deficiency occurs as the result of many diseases, i.e. malabsorption syndrome, liver disease, 
chronic renal disease, sickle cell disease, and other chronic illnesses [208].  The extensive literature 
with excellent reviews on oxidative stress in most of these diseases should prompt the reader to 
“think zinc” in all cases.  The physician should evaluate the zinc status and consider proper zinc 
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nutriture and supplementation as therapeutic approaches or preventive measures as zinc has been 
shown to be efficacious in protecting several organs and tissues against stressors, inflammation and 
fibrotic processes.
The relationship is also important for toxicology and pharmacology with many examples of 
environmental pollutants, toxins, or drugs interfering directly with zinc metabolism, conditioning a 
zinc deficiency or inducing oxidative stress.  Nutrition has a primary role in determining the 
antioxidant status in the first place.  In as much as there are genetic factors that affect redox biology, 
numerous mutations in the proteins controlling zinc homeostasis have been discovered recently 
[208].  It will be exciting to learn how these mutations affect redox metabolism.    
In addition to many of the listed diseases increasing with age and being considered age-related, 
there is the overarching issue that ageing itself has always been linked with oxidative stress.  Very 
pertinent to etiology and ageing is that zinc deficiency develops in the elderly with a decline of the 
immune system and a low grade inflammation as documented in some but not all countries [210].  
Over the entire life course, zinc deficiency is wide-spread and a significant factor for morbidity and 
mortality in the developing and even the developed world.  It has been estimated that 82% of 
pregnant women are zinc-deficient, which can be a serious risk factor for child development and 
physical and mental health later in life [211].
A major difference to iron metabolism, for which many clinical markers exist and imbalances are 
clinically much more readily defined, is that the only general clinical marker for zinc status is serum 
zinc.  It does not necessarily reflect zinc status in tissues and cells because zinc in blood is only 0.1% 
of the total.  Finally, there is the issue that zinc supplementation, while indicated when plasma zinc 
is low, has met with mixed results in many of the diseases accompanied by oxidative stress.  Based 
on the foregoing discussions, oxidative stress may need to be controlled in order to restore zinc-
dependent functions efficiently through zinc supplementation [212].
7 Conclusions
A molecular basis is emerging for significant roles of signalling zinc ions in cellular regulation and 
redox homeostasis (Figure 8).  Redox and zinc biology are linked and tightly controlled to perform 
fundamental biochemical functions.  The cellular redox and zinc states are dynamic.   Induced 
fluctuations are used for signalling.  The article attempted to show how important zinc is for redox 
biology, namely that zinc deficiency causes oxidative stress, oxidative stress causes zinc re-
distribution, and the redox activity of zinc thiolate coordination environments impacts protein 
structure and function.  Specifically, redox modulation confers coordination dynamics on zinc finger 
sites that are perceived as permanent fixtures of proteins [213].  The relationship between zinc and 
redox biology has enormous implications for physiology and virtually all diseases associated with 
oxidative stress.  From the original observations of damage to biomolecules and generation of 
reactive species under zinc deficiency the notion developed that zinc has antioxidant-like properties.  
The postulated mechanisms underlying such an action, namely that zinc protects sulfhydryls from 
oxidative modification and that zinc suppresses the generation of free radicals by outcompeting 
redox-active transition metal ions, is contestable.  Zinc-bound thiolates are not necessarily protected 
but reactive.  Zinc has a role in regulating the antioxidant defence by restoring the redox poise and 
controlling the synthesis of reducing thiol-containing biomolecules such as metallothionein and 
glutathione via activation of MTF-1-dependent gene transcription.  Competition with iron and 
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copper occurs outside cells during uptake of metal ions but inside cells metal ions are tightly 
buffered and it is less the competition between metal ions but rather the interdependence of their 
metabolism that is important for redox biology.  The biological significance of zinc is evident when 
compared to iron: While 2% of all proteins utilize iron as a cofactor, 10% of all proteins utilize zinc in 
structure and catalysis.  The regulatory functions of signalling zinc ions on proteins are in addition to 
the functions of zinc in a myriad of zinc proteins and biomolecular interactions and to the cellular 
control performed by calcium signalling.  To distinguish physiological from pathophysiological 
fluctuations of zinc ion concentrations it is necessary to measure the affinity of proteins for zinc and 
the very low concentrations of signalling Zn2+, which are three orders of magnitude lower than those 
of Ca2+.  Such determinations became possible only with designed fluorescent probes and sensors 
and continue to be challenging [214].  Advances will come from further mapping the chain of events 
in signalling and evaluating the different concentration ranges of zinc ions and their targets as 
physiologically, pharmacologically or toxicologically significant.  The majority of investigations have 
been performed with isolated proteins and cultured cells.  Translation to the situation in humans for 
improving health is lagging behind and will require specific marker for cellular zinc status and new 
types of interventions.  One would hope that closer interactions between the communities of zinc 
biologists and redox biologists will foster the adoption of methods and protocols to measure 
simultaneously redox and zinc species with the aim of understanding their joint contributions to 
health and disease.
Figure 8  Zn2+ in cellular regulation and interdependence with redox signalling and redox metabolism.  
Modification of thiols in metallothionein (MT) and phosphorylation of the zinc channel Zip7, a 
gatekeeper of a zinc store in the ER, increase cellular “free” zinc [Zn2+]i, generating a zinc signal that 
affects key enzymes in signal transduction pathways and activates MTF-1- and Nfr-2-dependent 
gene transcription that includes an antioxidant response involving thionein (T) and enzymes of 
glutathione synthesis.  Zinc transporters (ZnTs) dampen the zinc signal, store zinc in organelles, 
specific exocytotic vesicles, or export any surplus.  Vesicular exocytosis of zinc generates 
extracellular zinc signals [Zn2+]e for various purposes.  The system that controls zinc signals is part of 
the overall system of cellular homeostatic control.
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Footnote (page 3)
† The term oxidative stress for a redox imbalance is widely accepted.  It comprises different 
situations: reductive stress, a surplus of reactive species, and effects on redox signalling.
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